EGFR and glioblastoma: Our data revealed that EFEMP1 is a favorable prognostic factor for GBM, has a tumor-suppressive effect in malignant glioma cells, and acts in the extracellular compartment via independent blocking of EGFR and AKT signaling pathways while also repressing VEGFA-induced angiogenesis.